Scenario | Percentage of patients preferring a specific option | |||
---|---|---|---|---|
Methotrexate | Gold | Leflunomide | Etanercept | |
Base case | 1.7 (1.2) | 2.5 (1.4) | 0.8 (0.8) | 95.0 (2.0) |
All equally effective | 4.2 (1.8) | 7.5 (2.4) | 1.0 (0.8) | 87.5 (3.0) |
All equally effective, co-pay of etanercept increased to $30.00 | 5.8 (2.1) | 10.8 (2.8) | 3.3 (1.6) | 80.0 (3.7) |